Paper41383642
Burden and trends of cardiovascular diseases attributable to high LDL-C in China, 1990-2021: an age-period-cohort analysis with projectioans to 2050.
Li J and 8 others. Front Cardiovasc Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Burden and trends of cardiovascular diseases attributable to high LDL-C in China, 1990-2021: an age-period-cohort analysis with projectioans to 2050. Papers, record 41383642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41383642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Burden and trends of cardiovascular diseases attributable to high LDL-C in China, 1990-2021: an age-period-cohort analysis with projectioans to 2050.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37914585 | Global Trends in Atherosclerotic Cardiovascular Disease. | Clin Ther | 2023 | https://conductscience.org/library/papers/37914585 | PubMed |
| 2 | 30955975 | Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. | Lancet | 2019 | https://conductscience.org/library/papers/30955975 | PubMed |
| 3 | 40441814 | The epidemiology and burden of cardiovascular diseases in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021. | Lancet Public Health | 2025 | https://conductscience.org/library/papers/40441814 | PubMed |
| 4 | 32972526 | Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. | J Am Coll Cardiol | 2020 | https://conductscience.org/library/papers/32972526 | PubMed |
| 5 | 27351744 | Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. | PLoS Med | 2016 | https://conductscience.org/library/papers/27351744 | PubMed |
| 6 | 22732744 | Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. | Arch Intern Med | 2012 | https://conductscience.org/library/papers/22732744 | PubMed |
| 7 | 40386247 | National and Subnational Burden of Cardiovascular Diseases in Iran from 1990 to 2021: Results from Global Burden of Diseases 2021 study. | Glob Heart | 2025 | https://conductscience.org/library/papers/40386247 | PubMed |
| 8 | 37352395 | Effects of therapeutic lifestyle change diets on blood lipids, lipoproteins, glycemic parameters, and blood pressure: a systematic review and meta-analysis of clinical trials. | Nutr Rev | 2024 | https://conductscience.org/library/papers/37352395 | PubMed |
| 9 | 28444290 | Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. | Eur Heart J | 2017 | https://conductscience.org/library/papers/28444290 | PubMed |
| 10 | 30467329 | Epidemiology of cardiovascular disease in China: current features and implications. | Nat Rev Cardiol | 2019 | https://conductscience.org/library/papers/30467329 | PubMed |
| 11 | 37260036 | Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. | J Am Heart Assoc | 2023 | https://conductscience.org/library/papers/37260036 | PubMed |
| 12 | 40612949 | Impact of smoking on the complement system: a narrative review. | Front Immunol | 2025 | https://conductscience.org/library/papers/40612949 | PubMed |
| 13 | 38047351 | Changing Patterns of Stroke and Subtypes Attributable to High Systolic Blood Pressure in China From 1990 to 2019. | Stroke | 2024 | https://conductscience.org/library/papers/38047351 | PubMed |
| 14 | 40400054 | Long-term alcohol consumption and incident health risk conditions related to cardiometabolic risk markers: A 20-year prospective cohort study. | Addiction | 2025 | https://conductscience.org/library/papers/40400054 | PubMed |
| 15 | 29622441 | Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. | Int J Cardiol | 2018 | https://conductscience.org/library/papers/29622441 | PubMed |
| 16 | 38295785 | Age-Period-Cohort Analysis of Long-Term Trends in Ischemic Stroke Mortality in China Caused by Specific Risk Factors from 1990 to 2019. | Neuroepidemiology | 2024 | https://conductscience.org/library/papers/38295785 | PubMed |
| 17 | 3629048 | Models for temporal variation in cancer rates. II: Age-period-cohort models. | Stat Med | 1987 | https://conductscience.org/library/papers/3629048 | PubMed |
| 18 | 30740247 | Urban-rural differences in the association between blood lipids and characteristics of the built environment: a systematic review and meta-analysis. | BMJ Glob Health | 2019 | https://conductscience.org/library/papers/30740247 | PubMed |
| 19 | 39023892 | Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39023892 | PubMed |
| 20 | 29231837 | The primary health-care system in China. | Lancet | 2017 | https://conductscience.org/library/papers/29231837 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41383642
GET https://conductscience.org/api/papers/v1/41383642/references?page=2